AIDA Antikörper (AA 54-284) (FITC)
Kurzübersicht für AIDA Antikörper (AA 54-284) (FITC) (ABIN7971730)
Target
Alle AIDA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 54-284
-
Verwendungszweck
- Anti-AIDA Antibody FITC Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human AIDA recombinant protein (Position: E54-R284).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- AIDA (Axin Interactor, Dorsalization Associated (AIDA))
-
Andere Bezeichnung
- AIDA
-
Hintergrund
-
Background: Predicted to enable phosphatidylinositol binding activity. Acts upstream of or within negative regulation of JUN kinase activity. Predicted to be located in cytoplasm. Predicted to be active in membrane.
Gene Full Name: axin interactor, dorsalization associated
-
Gen-ID
- 64853
-
UniProt
- Q96BJ3
Target
-